Table 1.
Study patient characteristics at follow-up time points
| Study patient characteristics
| |||
|---|---|---|---|
| Characteristics N=137 |
6 months follow-up N=58 |
12 months follow-up N=51 |
24 months follow-up N=28 |
| Sex | |||
| Male | 37 (64%) | 35 (69%) | 20 (71%) |
| Female | 21 (36%) | 16 (31%) | 8 (29%) |
| Age (years) | 60.4 ± 13.1 | 61.3 ± 11.6 | 63.0 ± 11.6 |
| BMI (kg/m2) | 25.3±3.5 | 26.1±3.2 | 27.7±4.1 |
| Stage | |||
| 0+I | 7 (12%) | 9 (18%) | 4 (14%) |
| II | 18 (31%) | 16 (31%) | 11 (39%) |
| III | 18 (31%) | 15 (29%) | 11 (39%) |
| IV | 6 (10%) | 4 (7%) | 1 (4%) |
| Unknown | 9 (16%) | 7 (14%) | 1 (4%) |
| Previous adjuvant chemotherapy (n, %) | 15 (26%) | 16 (31%) | 7 (25%) |
| 25(OH)D3 (ng/mL) | 17.51 ± 10.63 | 17.80 ± 11.55 | 18.11 ± 8.80 |
| Deficient status, <20ng/mL, (n, %) | 38 (66%) | 34 (67%) | 17 (61%) |
| Total PA/week (mins) | |||
| Accelerometer | 1,320 ± 387 | 1,304 ± 399 | 1,268 ± 343 |
| Questionnaire | 551 ± 384 | 530 ± 505 | 596 ± 406 |
| Light PA/week (mins) | |||
| Accelerometer | 1,082 ± 299 | 1,056 ± 321 | 1,056 ± 281 |
| Questionnaire | 168 ±158 | 68 ± 112 | 74 ± 119 |
| Moderate PA/week (mins) | |||
| Accelerometer | 222 ± 156 | 236 ± 165 | 197 ± 131 |
| Questionnaire | 325 ± 266 | 246 ± 285 | 249 ± 182 |
| Vigorous PA/week (mins) | |||
| Accelerometer | 16 ± 47 | 12 ± 23 | 15 ± 39 |
| Questionnaire | 27 ± 95 | 50 ± 102 | 23 ± 68 |
| Moderate-to-vigorous PA/week (mins) | |||
| Accelerometer | 238 ± 176 | 248 ± 165 | 212 ± 148 |
| Questionnaire | 352 ± 255 | 296 ± 324 | 272 ± 182 |
Values are means ± SD
Abbreviations: BMI, body mass index; PA, physical activity; mins, minutes; MVPA, moderate-to-vigorous physical activity